The evidence: (i) Conventional vs intensive insulin therapy Key CER: control event rate EER: experimental group event rate RRR: relative risk reduction ARR: absolute risk reduction NNT: number needed to treat The evidence: (ii) Hydrocortisone alone vs hydrocortisone and fludrocortisone Outcome Time to outcome CER EER RRR ARR NNT Death Hospital discharge 0.458 0.429 6% 0.029 NS 95% confidence intervals: -13 to 25% -0.057 to 0.115 Death 180 days 0.485 0.457 6% 0.028 NS 95% confidence intervals:
Three part clinical question: Patients: Adult intensive care unit (ICU) patients in septic shock receiving hydrocortisone. Intervention: (i) Control of blood glucose using intensive or conventional insulin therapies, (ii) Fludrocortisone therapy in addition to hydrocortisone. Outcome: In-hospital 90-day, 180-day mortality.
Search terms: septic shock; RCT; intervention; mortality; corticosteroid; insulin; therapy.
The study: 2x2 factorial design, non-blinded, randomised controlled trial with intention-to-treat analysis.
The study patients: 509 adults with multi-organ dysfunction secondary to septic shock who received hydrocortisone treatment.
All patients: Received appropriate, audited management as per the Surviving Sepsis campaign guidelines.
Control group: (i) (n=138, 138 analysed) received 'conventional' glucose control therapy and hydrocortisone, (ii) (n=116, 116 analysed), received 'conventional' glucose control, hydrocortisone and fludrocortisone.
Experimental group (i) (n=126, 126 analysed) received intensive insulin control and hydrocortisone, (ii) (n=129, 129 analysed) received intensive insulin control, hydrocortisone and fludrocortisone.
EBM questions: 1. Do the methods allow accurate testing of the hypothesis?
Yes. The study allows comparison between intensive and conventional insulin therapy and also the effect of the addition of fludrocortisone. 2. Do the statistical tests correctly test the results to allow differentiation of statistically significant results? Yes. Mortality in the control group was almost exactly as predicted, suggesting the study was sufficiently powered to detect a true difference. 3. Are conclusions valid in light of the results? Yes. The study failed to show benefit with either intensive insulin therapy or the addition of fludrocortisone. The authors state their
Blood glucose control in patients on corticosteroids -does it affect mortality?
Intensive insulin therapy compared to conventional insulin therapy does not improve in-hospital mortality among patients treated with hydrocortisone for septic shock.
The addition of fludrocortisone to hydrocortisone does not improve mortality in septic shock.
Level of evidence: 1 + (RCT with a low risk of bias)
Appraised by: N Crutchley study does not support the hypothesis that intensive insulin therapy reduces the relative risk of death in patients with septic shock treated with hydrocortisone. 4. Did results get omitted, and why? All patients were followed up to the primary end point of ICU or 180-day mortality (whichever was the sooner). Twenty-five patients (4.9%) were lost to follow up after hospital discharge. 5. Did they suggest areas of further research? Yes. The original insulin studies detected a 32% relative risk reduction in mortality. This study failed to demonstrate that degree of success. Further studies should be aimed at smaller RRR. 6. Did they make any recommendations based on the results and were they appropriate? No. They simply stated that their data did not support the use of intensive insulin therapy or the addition of fludrocortisone in this patient group. 7. Is the study relevant to my clinical practice? Yes. This group of patients is commonly encountered in intensive care medicine and both the management of blood glucose and the use of fludrocortisone are current areas of controversy in ICU. 8. What level of evidence does this study represent? 1 + . 9. What grade of recommendation can I make on this result alone? B. 10.What grade of recommendation can I make when this study is considered along with other available evidence? B. 11.Should I change my practice because of these results? With regard to intensive insulin therapy -Yes. Having a more tightly controlled blood glucose does not appear to confer benefit and there is a risk of hypoglycaemia. Use of fludrocortisone is optional in the Surviving Sepsis Guidelines and this study does nothing to support its use in septic patients. 12.Should I audit my current practice because of these results?
Yes, with regard to efficacy of local tight glycaemic control protocols, effect on mortality and risk of hypoglycaemia.
Appraised by: Nicholas Crutchley, ST5 Anaesthetics, Stirling Royal Infirmary, nicholas.crutchley@nhs.net
